We Address Unmet Medical Needs to Improve Patient Outcomes and Quality of Life
EffRx Pharmaceuticals Signs Exclusive Licensing Agreement With Radius Health To Commercialize BINOSTO® In The United States.
The product portfolio is led by already commercialized Binosto® for the treatment of postmenopausal osteoporosis.
Partnering with us
Our strategy relies on partnerships for shared commercial success.